21 – 24/10/2021,
Hotel Du Lac,
Ioanina, Greece

IASIS PHARMA participated (with sponsorship) in the 41st Panhellenic Gastroenterological Conference, held under the auspices of the Hellenic Gastroenterological Society (EGE), at Hotel Du Lac in Ioannina, on 21 – 24/10/2021.

IASIS PHARMA presented the unique herbal medicine [E.M.A. 2015], mastiha var.Chia®caps, which can be used against functional dyspepsia, with the natural Chios mastic (Pistacia lentiscus var chia, 350mg) as its active ingredient.

Previously, the lack of a monograph on the analysis of the components of Chios mastic resin, had created a serious gap in the control of the quality of the product itself and its by-products.

Recently, IASIS PHARMA Research and Development department, in collaboration with the School of Pharmacy, of the University of Athens, elaborated the Development of Analytical Methods for the Qualitative Determination of the Active Ingredients of Chios mastic, as well as the Quantitative Determination of its main Components, as the only reliable analytical approach for Chios mastic quality control, along with the confrontation of any potential case of merchantry fraud.

Consequently, IASIS PHARMA, using the relevant technology and the suitable scientific “know-how”, offers Updated Data, Important Scientific Facts & the Latest Developments, regarding this unique herbal product that has a wide range of beneficial, but mainly therapeutical indications for human beings.